I don't think it would be a good idea for traders to be short on ABS right now. A lot of interest by the instos and it wont be to long before it fills the gap between the 25/2 and the 26/2.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor